rhEGF
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for rhEGF, covering 2014-08-04 to 2023-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Evaluation of the Intralesional Recombinant Human Epidermal Growth Factor (rhEGF) in Subjects With Diabetic Foot Ulcer. [Phase 3]